Impact of Silymarin Dosages to Decrease Drug-induced Elevated Liver Enzymes Compared to Placebo

Clinical trial NCT05144217 · COMPLETED

Trial details

NCT number: NCT05144217
Sponsor: Prof. Dr. Frank Behrens
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Drug-induced Liver Injury

Start date: 2021-06-23
Primary completion: 2024-12-12
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.